How much is Claris Bio worth in 2026?

Claris Bio has a current valuation of $163.4M based on their Later Stage VC round and secondary market data.

How much funding has Claris Bio raised?

Claris Bio has raised $153.6M in total funding across 1 funding rounds.

Claris Bio

Drug DiscoveryWebsite

Claris Bio valuation and funding history | Last updated: November 25, 2025 | 1 funding rounds

Current Valuation

$163.4M

As of November 25, 2025

Total Funding Raised

$153.6M

Across 1 round

Last Round

Later Stage VC

$93.5M

Last Funding

Nov 2025

Funding date

Capital Efficiency

1.06x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 4, 2024	Later Stage VC (Series A)	$54.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

Claris Bio is currently valued at $163.4M as of November 25, 2025. The company has raised a total of $153.6M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.06x, Claris Bio has achieved a valuation that is 1.06 times the total capital raised.

Track Claris Bio Valuation Updates

Get notified when Claris Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Claris Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Claris Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Claris Bio Worth in 2026?

Claris Bio is a leading private company in the Drug Discovery sector. Track Claris Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Claris Bio Valuation is Determined

Private company valuations like Claris Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.